Breaking News Instant updates and real-time market news.

FOLD

Amicus

$14.56

0.37 (2.61%)

07:05
08/07/18
08/07
07:05
08/07/18
07:05

Amicus reports Q2 EPS (33c), consensus (33c)

Reports Q2 revenue $21.3M, consensus $19.16M.

  • 07

    Aug

  • 13

    Aug

  • 12

    Sep

FOLD Amicus
$14.56

0.37 (2.61%)

09/15/17
JPMS
09/15/17
NO CHANGE
Target $15
JPMS
Overweight
JPMorgan continues to see upside in Amicus shares
JPMorgan analyst Anupam Rama says Amicus Therapeutics remains one of his top picks, and that he continues to see upside from current share levels, ahead of the upcoming Pompe data readout. The analyst sees a high probability that the Q3 data update will meet or exceed the efficacy benchmarks, leading to increased probability of success/revenue estimates across Street models. His base case, with a 75% probability of success assumption, still provides for 10%-15% upside from current share levels. His "homerun scenario," which is maintaining the 6MWD benefit shown in Q2 or better, has the stock rallying 35%-40%.
10/04/17
BOFA
10/04/17
NO CHANGE
Target $20
BOFA
Buy
Amicus price target raised to $20 from $15 at BofA/Merrill
BofA/Merrill analyst Tazeen Ahmad raised Amicus' price target to $20 from $15 saying the Phase 1/2 trial results of ATB200/AT2221 in Pompe disease were impressive. The analyst thinks the strong data justifies progression into pivotal trials and may result in an accelerated approval path. Ahmad rates Amicus a Buy.
04/11/18
JPMS
04/11/18
NO CHANGE
JPMS
Overweight
Amicus risk/reward favorable into regulatory update, says JPMorgan
JPMorgan analyst Anupam Rama notes that a regulatory update for Amicus Therapeutics' Pompe program is expected in Q2. The analyst continues to like the reward/risk profile of the shares going into the update. An accelerated approval path forward is "very much on the table," based on the strength of the Phase 1/2 data, Rama tells investors in a research note. He sees "more win scenarios than lose." The analyst believes Amicus shares can rally 30%-50% should an accelerated approval path forward emerge. Rama keeps an Overweight rating on Amicus with a $19 price target.
05/08/18
JPMS
05/08/18
NO CHANGE
JPMS
Amicus lower on Pompe program commentary, says JPMorgan
JPMorgan analyst Anupam Rama attributes today's post-earnings weakness in shares of Amicus Therapeutics to "conservative commentary" on the call related to the Pompe program. The analyst, however, does not believe that the regulatory scenarios he outlined last month for the program have fundamentally changed. Nonetheless, Rama thinks commentary on the call, particularly on timing, was perceived as cautious. Amicus shares are down 7.5% to $13.49 in midday trading.

TODAY'S FREE FLY STORIES

ADI

Analog Devices

$89.12

3.57 (4.17%)

06:33
11/21/18
11/21
06:33
11/21/18
06:33
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

AAPL

Apple

$177.10

-8.7 (-4.68%)

06:32
11/21/18
11/21
06:32
11/21/18
06:32
Periodicals
Apple in talks to provide veterans access to electronic health records, WSJ says »

Apple is in talks with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

SWGAY

Swatch Group

$0.00

(0.00%)

06:31
11/21/18
11/21
06:31
11/21/18
06:31
Downgrade
Swatch Group rating change  »

Swatch Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWGAY

Swatch Group

$0.00

(0.00%)

06:31
11/21/18
11/21
06:31
11/21/18
06:31
Downgrade
Swatch Group rating change  »

Swatch Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXCM

DexCom

$119.89

-1.34 (-1.11%)

, GOOG

Alphabet

$1,026.00

7 (0.69%)

06:28
11/21/18
11/21
06:28
11/21/18
06:28
Recommendations
DexCom, Alphabet, Alphabet Class A analyst commentary  »

Amended Verily agreement…

DXCM

DexCom

$119.89

-1.34 (-1.11%)

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

JD

JD.com

$19.49

-1.6 (-7.59%)

06:26
11/21/18
11/21
06:26
11/21/18
06:26
Periodicals
JD.com 'Singles Day' fueled by illegal student labor, FT reports »

Over 100,000 employees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$63.54

1.35 (2.17%)

06:26
11/21/18
11/21
06:26
11/21/18
06:26
Upgrade
Best Buy rating change  »

Best Buy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

DE

Deere

$138.49

-4.04 (-2.83%)

06:21
11/21/18
11/21
06:21
11/21/18
06:21
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere down 4.7% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

LOW

Lowe's

$86.15

-5.19 (-5.68%)

, HD

Home Depot

$169.17

-4.45 (-2.56%)

06:21
11/21/18
11/21
06:21
11/21/18
06:21
Downgrade
Lowe's, Home Depot rating change  »

Lowe's downgraded to…

LOW

Lowe's

$86.15

-5.19 (-5.68%)

HD

Home Depot

$169.17

-4.45 (-2.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJ

BJ's Wholesale

$19.85

-0.22 (-1.10%)

06:21
11/21/18
11/21
06:21
11/21/18
06:21
Recommendations
BJ's Wholesale analyst commentary  »

BJ's Wholesale is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNSKY

Danske Bank

$0.00

(0.00%)

06:21
11/21/18
11/21
06:21
11/21/18
06:21
Periodicals
Danske Bank faces money laundering lawsuit, FT reports »

Danske Bank is facing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCO

Columbus McKinnon

$34.04

-0.56 (-1.62%)

06:21
11/21/18
11/21
06:21
11/21/18
06:21
Conference/Events
Columbus McKinnon management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

DFS

Discover

$68.27

-1.315 (-1.89%)

06:19
11/21/18
11/21
06:19
11/21/18
06:19
Hot Stocks
Discover's Diners partners with Brazil's Elo to launch Elo Diners Club cards »

Discover's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMES

Emerge Energy

$2.73

0.03 (1.11%)

06:17
11/21/18
11/21
06:17
11/21/18
06:17
Recommendations
Emerge Energy analyst commentary  »

Emerge Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$138.49

-4.04 (-2.83%)

06:17
11/21/18
11/21
06:17
11/21/18
06:17
Hot Stocks
Deere CEO says company has 'continued to face cost pressures for raw materials' »

"John Deere has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

CLGX

CoreLogic

$39.31

-0.32 (-0.81%)

06:16
11/21/18
11/21
06:16
11/21/18
06:16
Conference/Events
CoreLogic management to meet with SunTrust »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

DE

Deere

$138.49

-4.04 (-2.83%)

06:15
11/21/18
11/21
06:15
11/21/18
06:15
Hot Stocks
Deere sees FY19 CapEx approximately $1.15B 

Up from $893M in FY18.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

DE

Deere

$138.49

-4.04 (-2.83%)

06:14
11/21/18
11/21
06:14
11/21/18
06:14
Earnings
Deere sees FY19 net income approximately $3.6B »

FY19 EPS consensus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

NSANY

Nissan

$0.00

(0.00%)

, RNSDF

Renault

$0.00

(0.00%)

06:13
11/21/18
11/21
06:13
11/21/18
06:13
Periodicals
Japan calls for stable alliance among Nissan, Renault, Mitsubishi, Reuters says »

Japan's Chief…

NSANY

Nissan

$0.00

(0.00%)

RNSDF

Renault

$0.00

(0.00%)

MMTOF

Mitsubishi Motors

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIX

Edison International

$52.80

-1.21 (-2.24%)

06:13
11/21/18
11/21
06:13
11/21/18
06:13
Upgrade
Edison International rating change  »

Edison International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$138.49

-4.04 (-2.83%)

06:12
11/21/18
11/21
06:12
11/21/18
06:12
Earnings
Deere sees FY19 equipment revenue up about 7%, consensus $36.04B »

Company equipment sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

ALB

Albemarle

$95.76

-3.825 (-3.84%)

06:11
11/21/18
11/21
06:11
11/21/18
06:11
Hot Stocks
Albemarle signs exclusivity agreement with Mineral Resources for lithium JV »

Albemarle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$138.49

-4.04 (-2.83%)

06:11
11/21/18
11/21
06:11
11/21/18
06:11
Earnings
Deere reports Q4 adjusted EPS $2.30, consensus $2.45 »

Reports Q4 equipment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

CAL

Caleres

$30.93

-1.165 (-3.63%)

06:10
11/21/18
11/21
06:10
11/21/18
06:10
Recommendations
Caleres analyst commentary  »

Caleres price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

06:10
11/21/18
11/21
06:10
11/21/18
06:10
Recommendations
Foot Locker analyst commentary  »

Foot Locker price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.